Tantech Holdings Announces 1-for-40 Common Share Consolidation
LISHUI, China, Feb. 11, 2025 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company"), announced today that the Company's Board of Directors approved on January 21, 2025 to effect a share consolidation of the Company's common...
Lithium Africa Resources Corp. Announces $6M Equity Financing and Intention to Complete a Listing on a Canadian Stock Exchange
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES LISBON, Portugal, Feb. 10, 2025 /PRNewswire/ -- Lithium Africa Resources Corp. ("Lithium Africa" or the "Company") is pleased to announce that...
Taoping Announces Major Cooperation with the Mengla County of Yunan Province; Expected Project Value of US$82.5 Million by 2027
SHENZHEN, China, Feb. 10, 2025 /PRNewswire/ -- Taoping Inc. (Nasdaq: TAOP, the "Company"), a provider of innovative smart cloud platform services and solutions, today revealed that it has entered into a non-binding strategic cooperation framework...
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met Endpoints
CBL-514, the world's first investigational drug for large-area localized fat reduction, has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3. 54.2% of participants in the CBL-514 group achieved at...
CStone Announces Inclusion of Cejemly® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline
SUZHOU, China, Feb. 10, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product,...
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first...
Axcelis Announces Participation in SEMICON Korea 2025
Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
CHENGDU, China, Feb. 8, 2025 /PRNewswire/ -- KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of Stapokibart...
ZK International Postpones Shareholder Call
WENZHOU, China, Feb. 8, 2025 /PRNewswire/ -- ZK International Group Co., Ltd. (Nasdaq: ZKIN) (" ZK International" or the "Company"), a leading engineering Company focused on high-performance steel products, announces that its previously scheduled...
SunCar Technology Group Announces Share Repurchase Program
NEW YORK, Feb. 7, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA), an innovative leader in cloud-based B2B auto services and auto e-insurance in China, today announced that its board of directors has...